A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 08 Aug 2016
At a glance
- Drugs Testosterone (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 02 Aug 2016 Planned primary completion date changed from 1 Dec 2018 to 1 Jan 2099.
- 02 Aug 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 18 Dec 2014 New trial record